Electromed, Inc. (AMEX: ELMD) Stock Competitors & Peer Comparison
See ELMD's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ELMD and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ELMD | $28.13 | -0.14% | 232.9M | 21.47 | $1.31 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.94 | -0.04% | 174.7B | 19.37 | $5.21 | +2.46% |
| MDT | $87.12 | -2.66% | 111.5B | 15.75 | $5.53 | +3.22% |
| SYK | $278.86 | +1.29% | 106.9B | 20.83 | $13.39 | +1.27% |
| BSX | $43.85 | -0.59% | 65.2B | 14.15 | $3.10 | N/A |
| EW | $88.11 | +1.47% | 50.7B | 32.63 | $2.70 | N/A |
| DXCM | $86.64 | -0.05% | 32.7B | 33.98 | $2.55 | N/A |
| GEHC | $66.46 | -0.48% | 30B | 14.57 | $4.56 | +0.21% |
| PHG | $24.77 | -1.35% | 24.2B | 14.15 | $1.75 | +3.94% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
ELMD vs BSX-PA Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ELMD's ROE is +0.23%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, ELMD is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
ELMD vs ABT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ABT has a market cap of 174.7B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ABT trades at $100.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ABT's P/E ratio is 19.37. In terms of profitability, ELMD's ROE is +0.23%, compared to ABT's ROE of +0.11%. Regarding short-term risk, ELMD is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ABT's competition here
Medtronic plc (NYSE: MDT)
ELMD vs MDT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, MDT has a market cap of 111.5B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while MDT trades at $87.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas MDT's P/E ratio is 15.75. In terms of profitability, ELMD's ROE is +0.23%, compared to MDT's ROE of +0.11%. Regarding short-term risk, ELMD is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
ELMD vs SYK Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SYK has a market cap of 106.9B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SYK trades at $278.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SYK's P/E ratio is 20.83. In terms of profitability, ELMD's ROE is +0.23%, compared to SYK's ROE of +0.16%. Regarding short-term risk, ELMD is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
ELMD vs BSX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BSX has a market cap of 65.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BSX trades at $43.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BSX's P/E ratio is 14.15. In terms of profitability, ELMD's ROE is +0.23%, compared to BSX's ROE of +0.15%. Regarding short-term risk, ELMD is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
ELMD vs EW Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, EW has a market cap of 50.7B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while EW trades at $88.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas EW's P/E ratio is 32.63. In terms of profitability, ELMD's ROE is +0.23%, compared to EW's ROE of +0.10%. Regarding short-term risk, ELMD is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
ELMD vs DXCM Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while DXCM trades at $86.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas DXCM's P/E ratio is 33.98. In terms of profitability, ELMD's ROE is +0.23%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, ELMD is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
ELMD vs GEHC Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, GEHC has a market cap of 30B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while GEHC trades at $66.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas GEHC's P/E ratio is 14.57. In terms of profitability, ELMD's ROE is +0.23%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, ELMD is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
ELMD vs PHG Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, PHG has a market cap of 24.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while PHG trades at $24.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas PHG's P/E ratio is 14.15. In terms of profitability, ELMD's ROE is +0.23%, compared to PHG's ROE of +0.10%. Regarding short-term risk, ELMD is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
ELMD vs ZBH Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ZBH has a market cap of 17.7B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ZBH trades at $91.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ZBH's P/E ratio is 10.77. In terms of profitability, ELMD's ROE is +0.23%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, ELMD is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
ELMD vs ABMD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ELMD's ROE is +0.23%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ELMD is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
ELMD vs SWAV Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ELMD's ROE is +0.23%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, ELMD is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
ELMD vs PEN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while PEN trades at $318.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas PEN's P/E ratio is 83.26. In terms of profitability, ELMD's ROE is +0.23%, compared to PEN's ROE of +0.11%. Regarding short-term risk, ELMD is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
ELMD vs SNN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SNN trades at $26.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SNN's P/E ratio is 18.19. In terms of profitability, ELMD's ROE is +0.23%, compared to SNN's ROE of +0.12%. Regarding short-term risk, ELMD is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
ELMD vs BIO-B Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, ELMD's ROE is +0.23%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, ELMD is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
ELMD vs ALGN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ALGN has a market cap of 10.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ALGN trades at $144.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ALGN's P/E ratio is 13.13. In terms of profitability, ELMD's ROE is +0.23%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, ELMD is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
ELMD vs BIO Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BIO trades at $379.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BIO's P/E ratio is 40.90. In terms of profitability, ELMD's ROE is +0.23%, compared to BIO's ROE of +0.03%. Regarding short-term risk, ELMD is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
ELMD vs GMED Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, GMED has a market cap of 10.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while GMED trades at $75.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas GMED's P/E ratio is 17.06. In terms of profitability, ELMD's ROE is +0.23%, compared to GMED's ROE of +0.12%. Regarding short-term risk, ELMD is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
ELMD vs BRKR Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BRKR trades at $64.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BRKR's P/E ratio is 32.42. In terms of profitability, ELMD's ROE is +0.23%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, ELMD is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
ELMD vs BRKRP Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BRKRP has a market cap of 9.5B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BRKRP trades at $472.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BRKRP's P/E ratio is 256.72. In terms of profitability, ELMD's ROE is +0.23%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, ELMD is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check BRKRP's competition here
Masimo Corporation (NASDAQ: MASI)
ELMD vs MASI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas MASI's P/E ratio is 44.43. In terms of profitability, ELMD's ROE is +0.23%, compared to MASI's ROE of +0.09%. Regarding short-term risk, ELMD is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
ELMD vs GKOS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, GKOS has a market cap of 9.4B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while GKOS trades at $158.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas GKOS's P/E ratio is -184.34. In terms of profitability, ELMD's ROE is +0.23%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, ELMD is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
ELMD vs PODD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, PODD has a market cap of 9.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while PODD trades at $132.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas PODD's P/E ratio is 22.63. In terms of profitability, ELMD's ROE is +0.23%, compared to PODD's ROE of +0.27%. Regarding short-term risk, ELMD is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check PODD's competition here
Haemonetics Corporation (NYSE: HAE)
ELMD vs HAE Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while HAE trades at $105.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas HAE's P/E ratio is 21.13. In terms of profitability, ELMD's ROE is +0.23%, compared to HAE's ROE of +0.11%. Regarding short-term risk, ELMD is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
ELMD vs NARI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas NARI's P/E ratio is -59.24. In terms of profitability, ELMD's ROE is +0.23%, compared to NARI's ROE of -0.00%. Regarding short-term risk, ELMD is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
ELMD vs ITGR Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ITGR's P/E ratio is 19.90. In terms of profitability, ELMD's ROE is +0.23%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, ELMD is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
ELMD vs LIVN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while LIVN trades at $76.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas LIVN's P/E ratio is 18.29. In terms of profitability, ELMD's ROE is +0.23%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, ELMD is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
ELMD vs IRTC Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while IRTC trades at $114.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas IRTC's P/E ratio is -265.63. In terms of profitability, ELMD's ROE is +0.23%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, ELMD is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
ELMD vs AXNX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ELMD's ROE is +0.23%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ELMD is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
ELMD vs TMDX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while TMDX trades at $84.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas TMDX's P/E ratio is 42.68. In terms of profitability, ELMD's ROE is +0.23%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, ELMD is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
ELMD vs NEOG Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, NEOG has a market cap of 2.8B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while NEOG trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas NEOG's P/E ratio is 45.46. In terms of profitability, ELMD's ROE is +0.23%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, ELMD is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
ELMD vs BFLY Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BFLY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BFLY's P/E ratio is -37.90. In terms of profitability, ELMD's ROE is +0.23%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, ELMD is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
ELMD vs UFPT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while UFPT trades at $296.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas UFPT's P/E ratio is 30.33. In terms of profitability, ELMD's ROE is +0.23%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, ELMD is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check UFPT's competition here
AxoGen, Inc. (NASDAQ: AXGN)
ELMD vs AXGN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while AXGN trades at $42.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas AXGN's P/E ratio is 111.68. In terms of profitability, ELMD's ROE is +0.23%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, ELMD is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
ELMD vs INSP Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, INSP has a market cap of 2.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while INSP trades at $73.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas INSP's P/E ratio is 32.26. In terms of profitability, ELMD's ROE is +0.23%, compared to INSP's ROE of +0.18%. Regarding short-term risk, ELMD is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check INSP's competition here
NuVasive, Inc. (NASDAQ: NUVA)
ELMD vs NUVA Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ELMD's ROE is +0.23%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ELMD is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
ELMD vs ESTA Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ESTA trades at $63.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ESTA's P/E ratio is -50.56. In terms of profitability, ELMD's ROE is +0.23%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, ELMD is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
ELMD vs NVCR Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while NVCR trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas NVCR's P/E ratio is -12.30. In terms of profitability, ELMD's ROE is +0.23%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, ELMD is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
ELMD vs ATEC Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ATEC trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ATEC's P/E ratio is -172.83. In terms of profitability, ELMD's ROE is +0.23%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, ELMD is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
ELMD vs CNMD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CNMD trades at $46.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CNMD's P/E ratio is 10.26. In terms of profitability, ELMD's ROE is +0.23%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, ELMD is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
ELMD vs HSKA Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ELMD's ROE is +0.23%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ELMD is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
ELMD vs IART Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while IART trades at $16.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas IART's P/E ratio is 7.05. In terms of profitability, ELMD's ROE is +0.23%, compared to IART's ROE of -0.01%. Regarding short-term risk, ELMD is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
ELMD vs AVNS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas AVNS's P/E ratio is 27.77. In terms of profitability, ELMD's ROE is +0.23%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, ELMD is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
ELMD vs TNDM Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while TNDM trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas TNDM's P/E ratio is -17.82. In terms of profitability, ELMD's ROE is +0.23%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, ELMD is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
ELMD vs SILK Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SILK's P/E ratio is -18.96. In terms of profitability, ELMD's ROE is +0.23%, compared to SILK's ROE of -0.35%. Regarding short-term risk, ELMD is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
ELMD vs AORT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while AORT trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas AORT's P/E ratio is 38.07. In terms of profitability, ELMD's ROE is +0.23%, compared to AORT's ROE of -0.01%. Regarding short-term risk, ELMD is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
ELMD vs IRMD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while IRMD trades at $86.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas IRMD's P/E ratio is 43.45. In terms of profitability, ELMD's ROE is +0.23%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, ELMD is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
ELMD vs FNA Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas FNA's P/E ratio is -19.83. In terms of profitability, ELMD's ROE is +0.23%, compared to FNA's ROE of -0.35%. Regarding short-term risk, ELMD is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
ELMD vs ENOV Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ENOV trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ENOV's P/E ratio is 5.29. In terms of profitability, ELMD's ROE is +0.23%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, ELMD is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
ELMD vs PRCT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while PRCT trades at $18.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas PRCT's P/E ratio is -9.39. In terms of profitability, ELMD's ROE is +0.23%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, ELMD is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
ELMD vs LMRI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, LMRI has a market cap of 985.8M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while LMRI trades at $10.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas LMRI's P/E ratio is -19.96. In terms of profitability, ELMD's ROE is +0.23%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, ELMD is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
ELMD vs BVS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BVS has a market cap of 948.5M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BVS trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BVS's P/E ratio is 18.42. In terms of profitability, ELMD's ROE is +0.23%, compared to BVS's ROE of +0.28%. Regarding short-term risk, ELMD is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
ELMD vs CBLL Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CBLL has a market cap of 943.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CBLL trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CBLL's P/E ratio is -14.12. In terms of profitability, ELMD's ROE is +0.23%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, ELMD is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
ELMD vs BBNX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BBNX has a market cap of 873.2M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BBNX trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BBNX's P/E ratio is -11.76. In terms of profitability, ELMD's ROE is +0.23%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, ELMD is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check BBNX's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
ELMD vs SIBN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SIBN has a market cap of 849.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SIBN trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SIBN's P/E ratio is -56.32. In terms of profitability, ELMD's ROE is +0.23%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, ELMD is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check SIBN's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
ELMD vs CSII Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CSII's P/E ratio is -20.83. In terms of profitability, ELMD's ROE is +0.23%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ELMD is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
ELMD vs INMD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, INMD has a market cap of 817.4M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while INMD trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas INMD's P/E ratio is 9.88. In terms of profitability, ELMD's ROE is +0.23%, compared to INMD's ROE of +0.12%. Regarding short-term risk, ELMD is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
ELMD vs VREX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas VREX's P/E ratio is 19.44. In terms of profitability, ELMD's ROE is +0.23%, compared to VREX's ROE of +0.05%. Regarding short-term risk, ELMD is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
ELMD vs AHCO Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, AHCO has a market cap of 771.4M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while AHCO trades at $5.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas AHCO's P/E ratio is 11.57. In terms of profitability, ELMD's ROE is +0.23%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, ELMD is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
ELMD vs CTKB Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CTKB has a market cap of 743.9M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CTKB trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CTKB's P/E ratio is -30.51. In terms of profitability, ELMD's ROE is +0.23%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, ELMD is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check CTKB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
ELMD vs AVR Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, AVR has a market cap of 738M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while AVR trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas AVR's P/E ratio is -3.91. In terms of profitability, ELMD's ROE is +0.23%, compared to AVR's ROE of -0.78%. Regarding short-term risk, ELMD is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
ELMD vs SRDX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SRDX's P/E ratio is -34.66. In terms of profitability, ELMD's ROE is +0.23%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, ELMD is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check SRDX's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
ELMD vs KIDS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, KIDS has a market cap of 584.6M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while KIDS trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas KIDS's P/E ratio is -19.29. In terms of profitability, ELMD's ROE is +0.23%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, ELMD is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
ELMD vs APEN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas APEN's P/E ratio is -9.43. In terms of profitability, ELMD's ROE is +0.23%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ELMD is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check APEN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
ELMD vs SSII Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SSII has a market cap of 578.4M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SSII trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SSII's P/E ratio is -48.17. In terms of profitability, ELMD's ROE is +0.23%, compared to SSII's ROE of -0.27%. Regarding short-term risk, ELMD is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check SSII's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
ELMD vs PACB Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, PACB has a market cap of 568.4M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while PACB trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas PACB's P/E ratio is -4.46. In terms of profitability, ELMD's ROE is +0.23%, compared to PACB's ROE of -49.62%. Regarding short-term risk, ELMD is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
ELMD vs DCTH Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, DCTH has a market cap of 547.2M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while DCTH trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas DCTH's P/E ratio is 1585.00. In terms of profitability, ELMD's ROE is +0.23%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, ELMD is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
ELMD vs ZIMV Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, ELMD's ROE is +0.23%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, ELMD is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ZIMV's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
ELMD vs SGHT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SGHT has a market cap of 508.7M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SGHT trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SGHT's P/E ratio is -16.70. In terms of profitability, ELMD's ROE is +0.23%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, ELMD is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check SGHT's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
ELMD vs TCMD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, TCMD has a market cap of 508.2M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while TCMD trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas TCMD's P/E ratio is 20.86. In terms of profitability, ELMD's ROE is +0.23%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, ELMD is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
ELMD vs CERS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CERS has a market cap of 497.8M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CERS trades at $2.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CERS's P/E ratio is -82.06. In terms of profitability, ELMD's ROE is +0.23%, compared to CERS's ROE of -0.10%. Regarding short-term risk, ELMD is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
ELMD vs NPCE Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, NPCE has a market cap of 475.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while NPCE trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas NPCE's P/E ratio is -24.46. In terms of profitability, ELMD's ROE is +0.23%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, ELMD is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
ELMD vs SENS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SENS has a market cap of 420M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SENS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SENS's P/E ratio is -4.51. In terms of profitability, ELMD's ROE is +0.23%, compared to SENS's ROE of -1.66%. Regarding short-term risk, ELMD is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
ELMD vs OFIX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, OFIX has a market cap of 394.1M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while OFIX trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas OFIX's P/E ratio is -6.35. In terms of profitability, ELMD's ROE is +0.23%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, ELMD is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
ELMD vs CLPT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CLPT has a market cap of 353M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CLPT trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CLPT's P/E ratio is -9.97. In terms of profitability, ELMD's ROE is +0.23%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, ELMD is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check CLPT's competition here
CapsoVision, Inc. (NASDAQ: CV)
ELMD vs CV Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CV has a market cap of 334.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CV trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CV's P/E ratio is -10.62. In terms of profitability, ELMD's ROE is +0.23%, compared to CV's ROE of -1.78%. Regarding short-term risk, ELMD is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
ELMD vs SMLR Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas SMLR's P/E ratio is 3.92. In terms of profitability, ELMD's ROE is +0.23%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, ELMD is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
ELMD vs TMCI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, TMCI has a market cap of 299.7M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while TMCI trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas TMCI's P/E ratio is -4.91. In terms of profitability, ELMD's ROE is +0.23%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, ELMD is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
ELMD vs CATX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, CATX has a market cap of 298.8M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while CATX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas CATX's P/E ratio is -1.97. In terms of profitability, ELMD's ROE is +0.23%, compared to CATX's ROE of -0.42%. Regarding short-term risk, ELMD is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check CATX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
ELMD vs RCEL Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, RCEL has a market cap of 297.1M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while RCEL trades at $11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas RCEL's P/E ratio is -8.31. In terms of profitability, ELMD's ROE is +0.23%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, ELMD is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
ELMD vs INFU Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, INFU has a market cap of 263M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while INFU trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas INFU's P/E ratio is 31.78. In terms of profitability, ELMD's ROE is +0.23%, compared to INFU's ROE of +0.15%. Regarding short-term risk, ELMD is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check INFU's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
ELMD vs TLSI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, TLSI has a market cap of 261.7M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while TLSI trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas TLSI's P/E ratio is -2.53. In terms of profitability, ELMD's ROE is +0.23%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, ELMD is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check TLSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
ELMD vs MGRM Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas MGRM's P/E ratio is -12.00. In terms of profitability, ELMD's ROE is +0.23%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, ELMD is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
ELMD vs NVRO Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ELMD's ROE is +0.23%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ELMD is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
ELMD vs PROF Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, PROF has a market cap of 207.9M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while PROF trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas PROF's P/E ratio is -5.84. In terms of profitability, ELMD's ROE is +0.23%, compared to PROF's ROE of -0.56%. Regarding short-term risk, ELMD is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
ELMD vs RXST Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, RXST has a market cap of 197.5M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while RXST trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas RXST's P/E ratio is -4.22. In terms of profitability, ELMD's ROE is +0.23%, compared to RXST's ROE of -0.17%. Regarding short-term risk, ELMD is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
ELMD vs BSGM Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas BSGM's P/E ratio is -5.81. In terms of profitability, ELMD's ROE is +0.23%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, ELMD is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check BSGM's competition here
Quantum-Si incorporated (NASDAQ: QSI)
ELMD vs QSI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, QSI has a market cap of 189.5M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while QSI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas QSI's P/E ratio is -2.08. In terms of profitability, ELMD's ROE is +0.23%, compared to QSI's ROE of -0.47%. Regarding short-term risk, ELMD is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check QSI's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
ELMD vs MDGS Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas MDGS's P/E ratio is -0.27. In terms of profitability, ELMD's ROE is +0.23%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, ELMD is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check MDGS's competition here
Quanterix Corporation (NASDAQ: QTRX)
ELMD vs QTRX Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, QTRX has a market cap of 172.9M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while QTRX trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas QTRX's P/E ratio is -1.44. In terms of profitability, ELMD's ROE is +0.23%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, ELMD is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
ELMD vs FOCL Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, FOCL has a market cap of 170.2M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while FOCL trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas FOCL's P/E ratio is -4.39. In terms of profitability, ELMD's ROE is +0.23%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, ELMD is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check FOCL's competition here
Neuronetics, Inc. (NASDAQ: STIM)
ELMD vs STIM Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, STIM has a market cap of 164.2M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while STIM trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas STIM's P/E ratio is -5.36. In terms of profitability, ELMD's ROE is +0.23%, compared to STIM's ROE of -1.51%. Regarding short-term risk, ELMD is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
ELMD vs QIPT Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas QIPT's P/E ratio is -15.87. In terms of profitability, ELMD's ROE is +0.23%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, ELMD is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
ELMD vs LUCD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, LUCD has a market cap of 154.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while LUCD trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas LUCD's P/E ratio is -2.19. In terms of profitability, ELMD's ROE is +0.23%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, ELMD is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check LUCD's competition here
Inogen, Inc. (NASDAQ: INGN)
ELMD vs INGN Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, INGN has a market cap of 145.4M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while INGN trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas INGN's P/E ratio is -5.90. In terms of profitability, ELMD's ROE is +0.23%, compared to INGN's ROE of -0.13%. Regarding short-term risk, ELMD is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
ELMD vs ICAD Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ICAD's P/E ratio is -20.37. In terms of profitability, ELMD's ROE is +0.23%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, ELMD is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
ELMD vs HJLI Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas HJLI's P/E ratio is N/A. In terms of profitability, ELMD's ROE is +0.23%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, ELMD is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check HJLI's competition here
electroCore, Inc. (NASDAQ: ECOR)
ELMD vs ECOR Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ECOR has a market cap of 98.1M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ECOR trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ECOR's P/E ratio is -6.48. In terms of profitability, ELMD's ROE is +0.23%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, ELMD is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for ELMD.Check ECOR's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
ELMD vs ASXC Comparison September 2026
Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELMD stands at 232.9M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, ELMD is priced at $28.13 on the AMEX, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELMD currently has a P/E ratio of 21.47, whereas ASXC's P/E ratio is -1.12. In terms of profitability, ELMD's ROE is +0.23%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, ELMD is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ASXC's competition here